A Place for Patent Protected and Unprotected Theranostic Approaches in Research and Clinic.

REPLY: I thank Dr. Notni for his recent letter in which he provides his perspective on one part of the success story of PSMA-targeted theranostics. Success stories often come with conflicts and intellectual ownership discussions. Dr. Notni makes important points. He acknowledges the pivotal role of